Wednesday, November 23, 2016 3:26:29 PM
ESCU had a 2 hour conference call with the SEC approximately 3 weeks ago. The SEC gave clear direction regarding what they wanted ESCU to change / add. ESCU was listening carefully. This 7th filing should move things much closer toward SEC approval.
ESCU should receive a response from the SEC within a couple of weeks.
Then, it's time for ESCU to shift gears and move forward.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM